Updated: Saturday 31 October 2026
- 7 companies of the 20 in the Nifty Healthcare Index index have reported Q2 FY27 results.
- Combined net profit: ₹5,861 crore, 23.01% lower than a year earlier.
- Combined revenue: ₹46,393 crore, 11.30% higher than a year earlier.
- Net profit margin: 12.63% (18.26% a year earlier).
- 13 companies still to report.
The Nifty Healthcare Index Q2 FY27 results show 7 companies have reported a combined net profit of ₹5,861 crore, which is 23.01% lower than a year earlier. These same companies generated a combined revenue of ₹46,393 crore, a figure 11.30% higher than the same quarter in the previous year.
Nifty Healthcare Index Q2 FY27 results: the combined numbers
| Q2 FY27 | A year earlier | Change | Companies | |
|---|---|---|---|---|
| Revenue from operations | 46,393 | 41,684 | +11.30% | 7 |
| Net profit | 5,861 | 7,612 | −23.01% | 7 |
| Net profit margin | 12.63% | 18.26% | −5.63 pts | 7 |
Combined figures add the companies that reported both the quarter and the same quarter a year earlier, so they compare like with like. A company that has not reported is not in them.
The combined net profit margin for these 7 companies stands at 12.63%, compared to 18.26% a year earlier. Net profit was higher in fewer than half of the companies. Most of the companies reported a lower net profit than a year earlier, with the 7 companies showing these results.
Nifty Healthcare Index companies that have reported Q2 FY27
| Company | Revenue from operations | Net profit | Revenue from operations change | Net profit change | Net profit margin |
|---|---|---|---|---|---|
| Sun Pharmaceutical | 16,199 | 1,995 | +11.88% | −36.16% | 12.32% |
| Dr. Reddy’s Laboratories | 8,698 | 913 | −1.48% | −31.69% | 10.50% |
| Cipla | 7,404 | 852 | −2.44% | −37.08% | 11.50% |
| Mankind Pharma | 4,338 | 716 | +17.33% | +37.67% | 16.51% |
| Torrent Pharmaceuticals | 4,979 | 534 | +50.79% | −9.64% | 10.73% |
| Laurus Labs | 2,206 | 436 | +33.44% | +124.27% | 19.77% |
| Max Healthcare Institute | 2,569 | 414 | +20.31% | −15.64% | 16.13% |
Sun Pharmaceutical recorded the largest net profit among the group at ₹1,995 crore. Laurus Labs saw the largest net profit change on a year earlier, with a figure 124.27% higher. Meanwhile, Cipla reported a net profit of ₹852 crore, which was 37.08% lower than the same quarter a year earlier.
Nifty Healthcare Index companies still to report
| Company | Board meeting |
|---|---|
| Abbott India | 5 Nov 2026 |
| Alkem Laboratories | Date not announced |
| APOLLOHOSP | Date not announced |
| Aurobindo Pharma | 4 Nov 2026 |
| Biocon | 4 Nov 2026 |
| Divi’s Laboratories | 7 Nov 2026 |
| Fortis Healthcare | 5 Nov 2026 |
| Gland Pharma | 6 Nov 2026 |
| Glenmark Pharmaceuticals | 5 Nov 2026 |
| Ipca Laboratories | 5 Nov 2026 |
| KIMS | 4 Nov 2026 |
| Lupin | 3 Nov 2026 |
| Zydus Lifesciences | 4 Nov 2026 |
Of the 20 companies in the index, 13 have yet to report their results. Lupin is scheduled to report on 2026-11-03, while Aurobindo Pharma, Biocon, and KIMS report on 2026-11-04. Several others, including Abbott India, Fortis Healthcare, Glenmark Pharmaceuticals, and Ipca Laboratories, have scheduled their meetings for 2026-11-05.
Nifty Healthcare Index Q2 FY27 results: FAQs
How did Nifty Healthcare Index companies do in Q2 FY27?
7 companies of the 20 in the Nifty Healthcare Index index have reported Q2 FY27 results. Their combined net profit was ₹5,861 crore, 23.01% lower than a year earlier. Combined revenue was ₹46,393 crore, 11.30% higher than a year earlier. Only companies with both quarters are added.
Which Nifty Healthcare Index company reported the largest net profit in Q2 FY27?
Sun Pharmaceutical, with a net profit of ₹1,995 crore, 36.16% lower than a year earlier.
Which Nifty Healthcare Index companies are yet to report Q2 FY27 results?
Abbott India, Alkem Laboratories, APOLLOHOSP, Aurobindo Pharma, Biocon, Divi’s Laboratories, Fortis Healthcare, Gland Pharma and 5 more. The table lists the board-meeting dates the companies have announced.
Results are the companies’ filings to the exchanges; board-meeting dates are from their notices. Calculations are by ThePip. For information only; not investment advice.